Skip to main content

Antipodes Partners Ltd

SEC CIK
0001652442
Latest filing
Aug 6, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Antipodes Partners Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
2
Since Q4 2025
Holdings of REGN by Antipodes Partners Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−97−100.0%Sold outHolders
Q1 202697$74.9K<0.1%00.0%UnchangedHolders
Q4 202597$74.9K<0.1%+97NewHolders